Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Neoplasms × Steroids × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Multiple Myeloma 7 Prostatic Neoplasms 3 Plasmacytoma 2 Paraproteinemias 2 Neoplasm Metastasis 2 Leukemia, Plasma Cell 2 Breast Neoplasms 2 Spinal Cord Compression 1 Recurrence 1 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Neoplasms, Germ Cell and Embryonal 1 Neoplasms 1 Myasthenia Gravis 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Mantle-Cell 1 Lymphoma, Follicular 1 Lymphoma 1 Hepatitis 1 Hemangioma 1 Head and Neck Neoplasms 1 Gallstones 1 Common Bile Duct Neoplasms 1 Common Bile Duct Diseases 1 Colorectal Neoplasms 1 Chemical and Drug Induced Liver Injury 1 Carcinoma, Intraductal, Noninfiltrating 1 Carcinoma, Hepatocellular 1 Bone Cysts 1 Anatomic Stage IV Breast Cancer AJCC v8 1 Anatomic Stage I Breast Cancer AJCC v8 1

Interventions

pembrolizumab 146 Gemcitabine 134 Paclitaxel 126 Carboplatin 116 Bevacizumab 108 Docetaxel 94 Cyclophosphamide 93 Cisplatin 92 Exercise 78 Nivolumab 77 Fluorouracil 73 Capecitabine 72 Dexamethasone 70 Irinotecan 62 Radiotherapy 57 Pemetrexed 57 Oxaliplatin 57 Standard of Care 55 Leucovorin 53 Cetuximab 47 Drug Therapy 45 Sorafenib 44 Erlotinib Hydrochloride 44 Doxorubicin 41 atezolizumab 40 Blood Specimen Collection 40 130-nm albumin-bound paclitaxel 37 trametinib 34 Ipilimumab 34 venetoclax 32

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04810156 2022-12-14

I-HEP

Herlev Hospital

Phase 2 Unknown

Hepatitis, Neoplasms, Chemical and Drug Induced Liver Injury

Data powered by HemOnc (CC BY 4.0) Colophon ⚡